Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value
📥 Value-Trades has Launched Excel Tool. Click here to Learn More.

Limited details are visible to free users.
Get the paid version for Just $5.00/month or $55.00/year (save 13%)
- ad-free and packed with premium features.

Click MSFT to see all details.

Advertisement
Stock: PETS
Book Value Per Share: $2.051
EPS: $0.01
EBITDA: $-20 M
Dividend Per Share: $None
Dividend Yield: 0.00 %
Dividend Payout Ratio: 0%
Market Cap: 68 M
Return on Assets (TTM): -14.10%
Price To Sales Ratio TTM: 0.345
Price To Book Ratio: 1.588
PEG Ratio: 2.58
EV To EBITDA: 0.628
P/E Ratio: None
Forward P/E Ratio: 17.92
Ex Dividend Date: 2023-08-11
Dividend Date: 2023-08-18
Shares Outstandig: 21 M
Return on Equity (TTM): -78.90%
Current Price: $3.19
Previous Close: $3.23
52 Week Low: $1.57
52 Week High: $5.58
Earning Date (within 30 days): N/A
50 Day MA: $2.502
200 Day MA: $3.104
Link to Yahoo (Key Statistics): PETS
Link to Yahoo (Analysis): PETS
Link to Yahoo (Summary): PETS
Advertisement
Advertisement
 
* Note: Prices are in Million (M) USD.
Description:
PetMed Express Inc (PETS)
PetMed Express, Inc. (PETS), operating as 1-800-PetMeds, is a premier online pet pharmacy headquartered in Delray Beach, Florida, offering a comprehensive range of prescription and over-the-counter pet medications and supplies. With a steadfast commitment to affordability, convenience, and superior customer service, PETS is strategically positioned to harness the robust growth in the pet care industry. The company aims to enhance its market share by focusing on high-quality healthcare solutions tailored to the needs of pet owners nationwide, thereby addressing the increasing demand for accessible pet healthcare services. As it continues to innovate and expand its product offerings, PetMed Express seeks to solidify its leadership in the pet pharmacy sector.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $36 M
Debt : $0 M
EBITDA : $4 M

Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Trade & services
Industry: Retail-drug stores and proprietary stores

Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 319.00

Since Forward PE Ratio is greater than 35, 0 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Error: Invalid cash flow data provided.

Using default values for calculation.
Based on default values, 1 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-03-31): $274 M
Revenue 5 Years Ago (2019-03-31): $283 M
Total Growth over 5 Years: -3.3%
5-Year Revenue CAGR (Historical): -0.7%
Forward 5-Year CAGR (Tapered): -0.6%

Since historical Revenue CAGR is between 0 - 5, 1 point assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-03-31): $20 M
Share Count 5 Years Ago (2020-03-31): $20 M

Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $0.01
Trailing 12-Month Earnings Per Share (EPS): $0.00
Average Earnings Per Share (EPS): $0.01
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0.00%

Since Dividend Per Share is less than or equal to 0, 0 point assigned.

Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Using last 20 valid ROE years (max 20).
Average ROE: 22.8%

Since Average ROE is greater than 20, 5 points assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $3.19
52-Week Low: $1.57
Threshold Price (15% Above 52-Week Low): $1.81

Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $68 M

Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on high P/E, we recommend do not exceed 0.20% exposure of Total Portfolio.
Warren Buffett's Owners' Earnings:
No positive free cash flow found (TTM or annual) to compute Owners' Earnings per share.
Note: Many fast-growing companies reinvest heavily, so Owners' Earnings may appear low. Consider other factors in your valuation.
Value-Trade has assigned 16 points to above PetMed Express Inc (PETS) stock.
Last 17 Years Avg PE 13.02, Fair Value PE 12, Industry Based PE 15, ROE Based PE 22.8, Risk-Free Anchored PE (25% MoS) 18.12. Based on these 5 values, average assigned is 16.19. Value-Trades has assined P/E value 16.00. An average (Current Year EPS + Next Year EPS) earning per share is $0.01.
Fair value using multiple P/Es (blended): $0.16 (PE 16.19 × EPS $0.01)
So the Final Fair Value is: $0.16

P/E Reference Summary
Using EPS: $0.01
Source P/E Ratio Implied Fair Value
Market (1 Yr Ago)395.81$3.96
17 Yrs Avg-PE13.02$0.13
Value-Trades Assigned16$0.16

Share this valuation:


Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement